MJA Podcasts 2020 Episode 15: SGLT2 inhibitors and diabetic ketoacidosis, with A/Prof Shane Hamblin

Associate Professor Shane Hamblin

Vol 212, Issue 7: 20 April, 2020. Associate Professor Peter (Shane) Hamblin is a consultant endocrinologist and Director of Diabetes and Endocrinology at Western Health in Victoria. He discusses SGLT2 inhibitors and the rare, but important risk of diabetic ketoacidosis. With MJA news and online editor, Cate Swannell. 22 mins, 19 secs.

More on Diabetes

View more
View more

Subscribe to MJA email alerts

No spam, you can unsubscribe anytime you want.

By providing your information, you agree to our Terms of Use and our Privacy Policy.

Thanks for Subscribing! Tell us more

Your email updates will use your name.

Good one! Your updates are coming

Thank you for subscribing to the MJA email alerts. Receive the latest content in your inbox.